Epi Labs Inc. — Form D

Epi Labs Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2026-04-30. The offering totals $16.1M, of which $14.8M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2026-04-30
• Form: D
• Accession: 0002131877-26-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $16.1M
• Amount sold: $14.8M
• Remaining: $1.3M
• Investors: 15
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-582353

Issuer

• Name: Epi Labs Inc.
• CIK: 0002131877
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 135 MISSISSIPPI STREET, SAN FRANCISCO, CA, 94107
• Phone: (510) 859-7764

Officers, directors & promoters (1)

More

• CIK 2131877 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search